Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHAT: Propranolol in Post-MI Patients
NCT00000492Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1977
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Propranolol with Placebo (2 arms). Primary endpoint: Mortality from all causes at 25 months. Started Sep 1977; status: completed.
02
Drugs
propranolol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00000492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000492.